𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia

✍ Scribed by Feussner, Giso; Dobmeyer, Jürgen; Nissen, Henrik; Hansen, Torben Stiig


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
626 KB
Volume
65
Category
Article
ISSN
0148-7299

No coin nor oath required. For personal study only.

✦ Synopsis


We report on a 20-year-old man with the combination of two independent familial lipoprotein disorders: heterozygous familial hypercholesterolemia (FH) and type I11 hyperlipoproteinemia (HLP). Familial hypercholesterolemia was diagnosed by elevated total and low density lipoprotein cholesterol levels and family history. By denaturing gradient gel electrophoresis, DNA sequencing and restriction fragment length polymorphism analysis, a G+A splice donor mutation in intron 3 of the proband's low density lipoprotein receptor gene was identified as the underlying molecular defect. This mutation was described previously as a receptor-negative founder mutation in Norway (FH-Elverum) and subsequently in 6 unrelated heterozygous English patients, creating a severe phenotype of familial hypercholesterolemia. Type I11 HLP was confirmed by homozygosity for apolipoprotein (apo) E2 and an elevated ratio of very low density lipoprotein cholesterol to serum triglycerides (0.40; normal ratio about 0.20). The patient has unusual flat xanthomas in the interdigital webs of the hands which are normally not found in either disease. These dermatological findings might therefore be indicative of the rare combination of both disorders of lipoprotein metabolism in one individual.


📜 SIMILAR VOLUMES


Duplication of exons 13, 14 and 15 of th
✍ N. Lelli; M. Ghisellini; S. Calandra; A. Gaddi; A. Ciarrocchi; D. A. Coviello; S 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 674 KB

During a survey of Italian patients with familial hypercholesterolemia (FH), we identified an FH heterozygous patient with a gross rearrangement of the low density lipoprotein (LDL) receptor gene. Southern blot analysis of the proband's DNA digested with restriction enzymes PvuII, BamHI, BglII and X

Clinical evaluation of three types of pl
✍ Akio Mimori; Koki Takahashi; Tadayuki Mitamura; Hirokazu Kato; Tamio Teramoto; I 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

Long-term plasmaphercsis (PP) therapy was studied in a 56-year-old patient with homozygous type IIa familial hypercholestcrolemia also suffering from severe coronary heart disease. Three different PP techniques, plasma exchange (PE), double-membrane-filtration plasmapheresis (DFP), and the recently